人瑞人才(06919.HK)靈活用工人數增至3.2萬人 第三季度毛利率升至9.1%
格隆匯10月22日丨人瑞人才(06919.HK)公告,由於靈活用工服務為集團的主要業務分部,集團一直專注於發展該業務分部及持續招聘靈活用工僱員以調配至客户。集團的靈活用工人數由2020年8月31日的30,327人增至2020年9月30日的31,717人,相當於增加1,390人或增長率約4.6%。
集團將向其客户提供優質的靈活用工服務,藉以繼續鞏固其在中國靈活用工行業的地位。
此外,集團截至2020年9月30日止三個月的未經審核收益及毛利分別約為人民幣7.33億元及人民幣6660萬元。截至2020年9月30日止三個月毛利率約為9.1%(截至2020年6月30日止六個月約為8.3%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.